nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Bayesian approach to the design of phase II clinical trials
|
Sylvester, Richard J. |
|
1991 |
12 |
5 |
p. 655- 1 p. |
artikel |
2 |
Abstracts
|
|
|
1991 |
12 |
5 |
p. 670- 1 p. |
artikel |
3 |
A clinical applications generator optimizing patient recruitment and data integrity within automated investigator groups
|
Van Bruwaene, B. |
|
1991 |
12 |
5 |
p. 681-682 2 p. |
artikel |
4 |
A clinical research management system
|
De Rosa, M. |
|
1991 |
12 |
5 |
p. 693- 1 p. |
artikel |
5 |
A clinical trials database as a research tool in medical care
|
Morris, Robert D. |
|
1991 |
12 |
5 |
p. 620- 1 p. |
artikel |
6 |
A comparative study of non-randomized and randomized controls
|
Ward, L.C. |
|
1991 |
12 |
5 |
p. 661- 1 p. |
artikel |
7 |
A comparison of computer and human coronary angiographic end-point measures
|
Mack, Wendy |
|
1991 |
12 |
5 |
p. 716- 1 p. |
artikel |
8 |
A comparison of odds ratio and relative risk models for binary data
|
le Cessle, S. |
|
1991 |
12 |
5 |
p. 619- 1 p. |
artikel |
9 |
A comparison of quality-of-life measures in a randomized trial
|
Glasziou, P.P. |
|
1991 |
12 |
5 |
p. 653- 1 p. |
artikel |
10 |
A computer generated patient tracking and accrual mechanism for clinical trials
|
Stark, Ryan M. |
|
1991 |
12 |
5 |
p. 717- 1 p. |
artikel |
11 |
A computer program for the design and the analysis of phase II cancer clinical trials with the triangular test
|
Bellissant, Eric |
|
1991 |
12 |
5 |
p. 710- 1 p. |
artikel |
12 |
A conditional probability sequential stopping rule for clinical trials
|
Snapinn, Steven M. |
|
1991 |
12 |
5 |
p. 637- 1 p. |
artikel |
13 |
A cost-benefit analysis: Certification of multiple visual acuity examiners per center in multicenter clinical trials
|
McCaffrey, Lee |
|
1991 |
12 |
5 |
p. 714- 1 p. |
artikel |
14 |
A criterion for the adequacy of a simple design when a complex model will be used for analysis
|
Aickin, Mikel |
|
1991 |
12 |
5 |
p. 560-565 6 p. |
artikel |
15 |
A database design for automated data management of multicenter clinical trials
|
Beller, Elaine M. |
|
1991 |
12 |
5 |
p. 620- 1 p. |
artikel |
16 |
Advantages and disadvantages of treatment preference designs for clinical trials
|
Holbrook, Janet T. |
|
1991 |
12 |
5 |
p. 622- 1 p. |
artikel |
17 |
A flaw in the generalized maximum likelihood estimate with a suggested repair
|
Chappell, Rick |
|
1991 |
12 |
5 |
p. 703- 1 p. |
artikel |
18 |
A funding mechanism for clinical trials: The clinical trial planning grant
|
Kurinij, Natalie |
|
1991 |
12 |
5 |
p. 683- 1 p. |
artikel |
19 |
A general measure of correlation for logistic model
|
El Hasnaoul, A. |
|
1991 |
12 |
5 |
p. 688-689 2 p. |
artikel |
20 |
Agreement assessment in multicenter clinical trials
|
Cesana, Bruno |
|
1991 |
12 |
5 |
p. 701-702 2 p. |
artikel |
21 |
A latent class model that allows triple-label immunophenotypic analysis of cells based upon double-label measurements
|
van Putten, W.L.J. |
|
1991 |
12 |
5 |
p. 690- 1 p. |
artikel |
22 |
Alert systems for post-marketing surveillance of adverse drug events— Methods and problems
|
Praus, M. |
|
1991 |
12 |
5 |
p. 659- 1 p. |
artikel |
23 |
Alternative methods for describing treatment benefits including quality-of-life considerations
|
Gelber, Richard |
|
1991 |
12 |
5 |
p. 638- 1 p. |
artikel |
24 |
A model-based approach to estimate the survival distributions of treatment groups in a clinical trial using longitudinal data
|
Dunlop, Dorothy D. |
|
1991 |
12 |
5 |
p. 667- 1 p. |
artikel |
25 |
Analysis of medical costs as a secondary end-point in a clinical trial
|
Smith, L.Richard |
|
1991 |
12 |
5 |
p. 638- 1 p. |
artikel |
26 |
Analysis of nonfatal outcomes in clinical trials when mortality is present
|
McMahon, Robert |
|
1991 |
12 |
5 |
p. 625- 1 p. |
artikel |
27 |
Analysis of outcome data from a randomized clinical trial with multiple subunits per unit of randomization
|
Lin, Lillian S. |
|
1991 |
12 |
5 |
p. 685- 1 p. |
artikel |
28 |
Analysis of prospective epidemiological studies involving an intermediate event: Applications of cox's survival model
|
Galai, Noya |
|
1991 |
12 |
5 |
p. 627- 1 p. |
artikel |
29 |
Analysis of recurrent events in superficial bladder cancer
|
Barton, Bruce A. |
|
1991 |
12 |
5 |
p. 688- 1 p. |
artikel |
30 |
Analysis of repeated measures in clinical trials using summary statistics
|
Frison, Lars |
|
1991 |
12 |
5 |
p. 632- 1 p. |
artikel |
31 |
Analysis of the circadian blood pressure curve in normal men
|
Thijs, Lutgarde |
|
1991 |
12 |
5 |
p. 646-647 2 p. |
artikel |
32 |
Analysis strategies for randomized studies with continuous outcomes: Post-intervention measurements versus change scores
|
Black, Dennis M. |
|
1991 |
12 |
5 |
p. 671- 1 p. |
artikel |
33 |
Analyzing edit queries to identify problems in data collection, edits, and management
|
Hoover, Brett A. |
|
1991 |
12 |
5 |
p. 649- 1 p. |
artikel |
34 |
An analysis of methods of communication in clinical trials
|
Sheridan, Lenore |
|
1991 |
12 |
5 |
p. 711- 1 p. |
artikel |
35 |
An analysis strategy for multi-dose combination drug clinical trials
|
Philips, James |
|
1991 |
12 |
5 |
p. 661- 1 p. |
artikel |
36 |
A new clinical trials design for aids research: The “measured-choice” design
|
Rochon, James |
|
1991 |
12 |
5 |
p. 621- 1 p. |
artikel |
37 |
A new strategy of method comparison in clinical chemistry with a improved sequential estimation procedure and diagnostic validation
|
Banik, Norbert |
|
1991 |
12 |
5 |
p. 705-706 2 p. |
artikel |
38 |
An illustration of survival analysis: A study of intensive care unit patients
|
Estarelles, R. |
|
1991 |
12 |
5 |
p. 673- 1 p. |
artikel |
39 |
A parallel dose-titration design to determine dose range in patients with stable chronic disease
|
Pun, Edward F.C. |
|
1991 |
12 |
5 |
p. 622-623 2 p. |
artikel |
40 |
A phase II design for therapies which may be ineffective
|
Garnsey, L. |
|
1991 |
12 |
5 |
p. 655-656 2 p. |
artikel |
41 |
Application of random effects regression to longitudinal psychiatric data
|
Ragin, Ann Barnett |
|
1991 |
12 |
5 |
p. 673- 1 p. |
artikel |
42 |
Application of regression tree method as a tool to analyze a clinical trial
|
Ulm, K. |
|
1991 |
12 |
5 |
p. 684- 1 p. |
artikel |
43 |
Applying the ISO/OSI model to distributed data entry systems
|
Balley, Lance R. |
|
1991 |
12 |
5 |
p. 677- 1 p. |
artikel |
44 |
A simulation study of estimators for rates of change in longitudinal studies with attrition
|
Wang, F. |
|
1991 |
12 |
5 |
p. 671- 1 p. |
artikel |
45 |
A simulation study on the behavior of variable-selecting algorithms in linear regression models
|
Kron, Martina |
|
1991 |
12 |
5 |
p. 674- 1 p. |
artikel |
46 |
A study of patient accrual patterns in 23 VA multicenter clinical trials
|
Henderson, William G. |
|
1991 |
12 |
5 |
p. 658- 1 p. |
artikel |
47 |
A test for a difference in a continuous outcome in a drug trial of fixed length when there are dropouts
|
Brown, Morton B. |
|
1991 |
12 |
5 |
p. 671- 1 p. |
artikel |
48 |
Bayesian analysis of neutron therapy trial
|
Abrams, Keith |
|
1991 |
12 |
5 |
p. 666-667 2 p. |
artikel |
49 |
Block designs with neighbor correlations
|
Derzko, Gerard |
|
1991 |
12 |
5 |
p. 660- 1 p. |
artikel |
50 |
BOB (Baseline or Better)-time: A new end-point to analyze marker data in aids therapies
|
Beltangady, Mohan |
|
1991 |
12 |
5 |
p. 702-703 2 p. |
artikel |
51 |
Cancer prevention trials using micronutrients: Design issues
|
Patterson, Blossom H. |
|
1991 |
12 |
5 |
p. 695- 1 p. |
artikel |
52 |
Characteristics of pharmacokinetic modelling in a phase I clinical trial of radiolabeled monoclonal antibody
|
Liu, Tiepu |
|
1991 |
12 |
5 |
p. 654-655 2 p. |
artikel |
53 |
Choice of a radiological end-point in the evaluation of the effect of drugs on atherosclerotic lesions of restenosis after angioplasty
|
Lievre, M. |
|
1991 |
12 |
5 |
p. 623-624 2 p. |
artikel |
54 |
Clinical trials of investigational antiepileptic drugs: Monotherapy designs
|
Pledger, Gordon W. |
|
1991 |
12 |
5 |
p. 622- 1 p. |
artikel |
55 |
Closed testing procedures for multiple end-point analysis
|
Hothorn, L. |
|
1991 |
12 |
5 |
p. 684- 1 p. |
artikel |
56 |
Comparative evaluation of the quality of life: Use of spitzer index in ovarian cancer trials
|
Beltangady, Mohan |
|
1991 |
12 |
5 |
p. 702- 1 p. |
artikel |
57 |
Comparative study of multiple testing procedures in phase II clinical trials
|
Seguret, F. |
|
1991 |
12 |
5 |
p. 718- 1 p. |
artikel |
58 |
Comparing different epidemiological studies: How to summarize risk associations in a consistent form
|
Thompson, S.G. |
|
1991 |
12 |
5 |
p. 656- 1 p. |
artikel |
59 |
Comparison of clinical trials regulatory requirements and practice between European community and United States
|
Herson, Jay |
|
1991 |
12 |
5 |
p. 658- 1 p. |
artikel |
60 |
Comparison of definitions of nearest neighbor distances in the case of censored data—A simulation study
|
Gefeller, Olaf |
|
1991 |
12 |
5 |
p. 703-704 2 p. |
artikel |
61 |
Comparison of methods for follow-up by mail
|
Mickel, Mary |
|
1991 |
12 |
5 |
p. 680- 1 p. |
artikel |
62 |
Comparison of quality of life in the program on the surgical control of hyperlipidemias (POSCH) by a standard instrument and a study specific questionnaire
|
Stuenkel, Meredith |
|
1991 |
12 |
5 |
p. 654- 1 p. |
artikel |
63 |
Competence, control, confirmation and refutation
|
Senn, Stephen |
|
1991 |
12 |
5 |
p. 643- 1 p. |
artikel |
64 |
Compliance in the physician's health study
|
Glynn, Robert J. |
|
1991 |
12 |
5 |
p. 672- 1 p. |
artikel |
65 |
Computer-assisted radiographic digitization in the assessment of total HIP implants
|
Gupta, Sunil Kumar |
|
1991 |
12 |
5 |
p. 664- 1 p. |
artikel |
66 |
Computerized management of treatment assignments
|
Van Natta, Mark |
|
1991 |
12 |
5 |
p. 692- 1 p. |
artikel |
67 |
Conducting clinical study of GCP standards in the Soviet union-case analysis
|
Vuorinen, J. |
|
1991 |
12 |
5 |
p. 683- 1 p. |
artikel |
68 |
Considerations in assessing risk factors for main ocular outcomes in the early treatment diabetic retinopathy study
|
Barton, Franca |
|
1991 |
12 |
5 |
p. 704- 1 p. |
artikel |
69 |
Coordinating center (COC) management of pre-randomization eligibility in the diabetes control and complications trial (DCCT)
|
Brenneman, Anne T. |
|
1991 |
12 |
5 |
p. 692- 1 p. |
artikel |
70 |
Corneal transplant follow-up study (CTFS)
|
Vall, A. |
|
1991 |
12 |
5 |
p. 698- 1 p. |
artikel |
71 |
Cumulative incidence functions should replace integrated cause-specific hazard functions to describe probabilities of competing events over time
|
Gelber, Richard D. |
|
1991 |
12 |
5 |
p. 624-625 2 p. |
artikel |
72 |
Data correction strategies for multicenter clinical trials employing distributed data entry systems
|
Kuntz, Timothy E. |
|
1991 |
12 |
5 |
p. 644-645 2 p. |
artikel |
73 |
Data entry training for a small clinical trial
|
Corley, Scott D. |
|
1991 |
12 |
5 |
p. 706- 1 p. |
artikel |
74 |
Datafax evaluated
|
Taylor, D.Wayne |
|
1991 |
12 |
5 |
p. 644- 1 p. |
artikel |
75 |
Data management concepts at the epidemiology data center
|
Swanson, Polly |
|
1991 |
12 |
5 |
p. 716-717 2 p. |
artikel |
76 |
Data management, design and implementation for the global utilization of streptokinase and t-PA for occluded coronary arteries study
|
Muhlbaler, Lawrence H. |
|
1991 |
12 |
5 |
p. 629-630 2 p. |
artikel |
77 |
Data management in a multicenter study when participating sites are independently conducting different interventions
|
Miller, J.P. |
|
1991 |
12 |
5 |
p. 628- 1 p. |
artikel |
78 |
Data tracking and recording techniques in a multicenter clinical trial
|
Cauch, Karen |
|
1991 |
12 |
5 |
p. 691- 1 p. |
artikel |
79 |
Design and analysis considerations in prophylactic studies in recurrent vaginal candidiasis
|
Ying Wang, |
|
1991 |
12 |
5 |
p. 699- 1 p. |
artikel |
80 |
Design and implementation of a new prospective randomized clinical trial using informations of subset analysis data from previous trials
|
Junichi Sakamoto, |
|
1991 |
12 |
5 |
p. 697- 1 p. |
artikel |
81 |
Design issues when a second drug confounds effects of the primary treatment
|
West, M.Stewart |
|
1991 |
12 |
5 |
p. 695- 1 p. |
artikel |
82 |
Detecting data errors with a statistical screens
|
Ledingham, Robert |
|
1991 |
12 |
5 |
p. 706-707 2 p. |
artikel |
83 |
Determination of sample size taking account of certain prior information
|
Masashi Goto, |
|
1991 |
12 |
5 |
p. 694-695 2 p. |
artikel |
84 |
Developing a quality control (QC) program for bone density measurements in a multicenter trial: The postmenopausal estrogen/progestin interventions (PEPI) experience
|
Wasilauskas, Carol H. |
|
1991 |
12 |
5 |
p. 715- 1 p. |
artikel |
85 |
Development of a computerized network for registration and randomization in a large-scale multicenter clinical trial
|
Santoro, E. |
|
1991 |
12 |
5 |
p. 691-692 2 p. |
artikel |
86 |
Development of standardized software for analysis of clinical data
|
Johnson, C. |
|
1991 |
12 |
5 |
p. 719- 1 p. |
artikel |
87 |
Does central monitoring of the timeless of forms result in a decrease in the quality of data
|
Koski, Beverly |
|
1991 |
12 |
5 |
p. 708- 1 p. |
artikel |
88 |
Does participation on concurrent clinical trials compromise the quality of the data or its timely submission
|
Palmer, Michael J. |
|
1991 |
12 |
5 |
p. 713-714 2 p. |
artikel |
89 |
Drug supply system for the post CABG studies clinical trial
|
Fox, Norma Lynn |
|
1991 |
12 |
5 |
p. 649- 1 p. |
artikel |
90 |
Dynamical therapeutic strategies in clinical trials an example from the field of vascular surgery
|
Schafer, Helmut |
|
1991 |
12 |
5 |
p. 662- 1 p. |
artikel |
91 |
Dynamic balance randomization for clinical trials
|
Leung, Oberon |
|
1991 |
12 |
5 |
p. 669- 1 p. |
artikel |
92 |
Early patient accrual for a multicenter clinical trial
|
Cauch, Karen |
|
1991 |
12 |
5 |
p. 717- 1 p. |
artikel |
93 |
Electronic clinical trials in a group of UN community doctors
|
Bourke, Alison |
|
1991 |
12 |
5 |
p. 645- 1 p. |
artikel |
94 |
Electronic compliance monitoring in clinical trials: Benefits and risks
|
Sahlroot, J.Todd |
|
1991 |
12 |
5 |
p. 716- 1 p. |
artikel |
95 |
Electronic coordinating center—The centralized model
|
Gross, Richard D. |
|
1991 |
12 |
5 |
p. 674- 1 p. |
artikel |
96 |
Estimating effects of change in individual risk factors in a multifactorial intervention trial with group randomization
|
Goetghebeur, Els |
|
1991 |
12 |
5 |
p. 639- 1 p. |
artikel |
97 |
Estimating subgroup treatment effects in clinical trials
|
Balley, Kent R. |
|
1991 |
12 |
5 |
p. 626-627 2 p. |
artikel |
98 |
Ethical and legal considerations in clinical trials: An overview of the European diversity
|
Duez, Nicole |
|
1991 |
12 |
5 |
p. 712- 1 p. |
artikel |
99 |
Evaluating the impact of a change in review committee membership in a multicenter clinical trial
|
Melia, Michele |
|
1991 |
12 |
5 |
p. 636- 1 p. |
artikel |
100 |
Evaluation of prognostic factors from world wide clinical trials on prostata cancer
|
Ringström, Jerker |
|
1991 |
12 |
5 |
p. 699- 1 p. |
artikel |
101 |
Exact inference about the ratio of within-subject variances in a 2 x 2 crossover trial uner weak assumptions about the between-subject variability
|
Gullbaud, Olivier |
|
1991 |
12 |
5 |
p. 659-660 2 p. |
artikel |
102 |
Expanded coordinating center role: The postmenopausal estrogen/progestin interventions (PEPI) Trial
|
Wells, H.Bradley |
|
1991 |
12 |
5 |
p. 679- 1 p. |
artikel |
103 |
Extended Mantel-Haenszel procedures for analyzing multicenter clinical trials
|
Davis, Charles S. |
|
1991 |
12 |
5 |
p. 686- 1 p. |
artikel |
104 |
Facing unexpected major interaction—Results from a trial on graves' disease
|
Fischer, Christine |
|
1991 |
12 |
5 |
p. 636- 1 p. |
artikel |
105 |
Factors affecting the sample size benefits of run-in strategies
|
Gordon, Mae E. |
|
1991 |
12 |
5 |
p. 651- 1 p. |
artikel |
106 |
Follow-up of trials funded by NIH in 1979: Evidence of publication bias
|
Dickersin, Kay |
|
1991 |
12 |
5 |
p. 634- 1 p. |
artikel |
107 |
Getting more power from pair-wise comparisons in a three group design while protecting the experiment-wise error rate
|
Thompson, Bruce |
|
1991 |
12 |
5 |
p. 685- 1 p. |
artikel |
108 |
Global tests of efficacy for multiple end-points when not all endpoints apply to each study patient
|
Alvir, Jose Ma.J. |
|
1991 |
12 |
5 |
p. 684- 1 p. |
artikel |
109 |
Guidelines for monitoring company sponsored clinical trials in the pharmaceutical industry
|
Banks, P.L.C. |
|
1991 |
12 |
5 |
p. 715-716 2 p. |
artikel |
110 |
Guidelines for simultaneous participation in two or more randomized trials
|
Simes, R.J. |
|
1991 |
12 |
5 |
p. 661-662 2 p. |
artikel |
111 |
Heterogeneity in meta-analysis: Potential strategy of identification, analysis and practical interpretation
|
Nony, P. |
|
1991 |
12 |
5 |
p. 700- 1 p. |
artikel |
112 |
24-hour blood pressure measurement; methods of analysis and data requirements
|
Dickson, Dorothy |
|
1991 |
12 |
5 |
p. 665-666 2 p. |
artikel |
113 |
How many repeated estimates of response are needed for reliable assessment of efficacy in clinical trials?
|
Szalai, John Paul |
|
1991 |
12 |
5 |
p. 633- 1 p. |
artikel |
114 |
How one data coordinating center resolved its computing literacy problems
|
Remaley, Nancy H. |
|
1991 |
12 |
5 |
p. 663- 1 p. |
artikel |
115 |
How to show the equivalence of two vaccines in a clinical trial
|
Albrecht, Neiss |
|
1991 |
12 |
5 |
p. 643- 1 p. |
artikel |
116 |
Imperfectly observed chronic disease histories: A monte-carlo approach to inference applied to cervical cancer screening data
|
Kirby, A.Jill |
|
1991 |
12 |
5 |
p. 639-640 2 p. |
artikel |
117 |
Implementation of concentration-controlled trials (CCTs)
|
Sanathanan, L. |
|
1991 |
12 |
5 |
p. 655- 1 p. |
artikel |
118 |
Implementing the European community (EC) good clinical practice guidelines in Canada: A national cooperative group's report
|
Paul, Nancy |
|
1991 |
12 |
5 |
p. 682-683 2 p. |
artikel |
119 |
Improved monitoring of multicenter trials by an extended database
|
Holle, Rolf |
|
1991 |
12 |
5 |
p. 707-708 2 p. |
artikel |
120 |
Improvement of short term aids incidence predictions by relating the logistic functions used for curve fitting actual data with a deterministic model describing the aids epidemic
|
de Haan, B.J. |
|
1991 |
12 |
5 |
p. 689-690 2 p. |
artikel |
121 |
Improvements of data quality at clinical trials applying a scientific physician computer interface
|
Werdler, Dieter |
|
1991 |
12 |
5 |
p. 663-664 2 p. |
artikel |
122 |
Inter-data center and inter-group collaboration: The EORTC experience
|
Thomas, Denis |
|
1991 |
12 |
5 |
p. 629- 1 p. |
artikel |
123 |
Intergroup participation—The challenge of multigroup trials
|
McFadden, Eleanor T. |
|
1991 |
12 |
5 |
p. 674-675 2 p. |
artikel |
124 |
Interim monitoring for vaccine efficacy
|
Reed, George F. |
|
1991 |
12 |
5 |
p. 669- 1 p. |
artikel |
125 |
Interim p-values for group sequentially monitored trials
|
Davis, Kathryn |
|
1991 |
12 |
5 |
p. 668- 1 p. |
artikel |
126 |
Interpreting “negative” meta-analysis: True lack of efficacy, mixture of heterogeneous trials or a type II error problem?
|
Leizorovicz, Alain |
|
1991 |
12 |
5 |
p. 656-657 2 p. |
artikel |
127 |
Intraclass correlation coefficient—methodology and applications
|
Müller, Reinhold |
|
1991 |
12 |
5 |
p. 690- 1 p. |
artikel |
128 |
Investigation of aickins measure of agreement
|
Kok, Frank G. |
|
1991 |
12 |
5 |
p. 628- 1 p. |
artikel |
129 |
Issues in sample size determination when replicate measures are observed
|
Rademaker, Alfred W. |
|
1991 |
12 |
5 |
p. 642- 1 p. |
artikel |
130 |
Issues in the design and analysis of factorial design trials: The international TPA/SK mortality trial
|
Simes, R.J. |
|
1991 |
12 |
5 |
p. 652- 1 p. |
artikel |
131 |
Length of follow-up in randomized clinical trials
|
Rockette, Howard E. |
|
1991 |
12 |
5 |
p. 662- 1 p. |
artikel |
132 |
Linking the program for randomization to the production of preprinted color coded specimen labels
|
Wasilauskas, Carol H. |
|
1991 |
12 |
5 |
p. 691- 1 p. |
artikel |
133 |
Locating patients lost to follow-up in clinical trials
|
Wiggins, Kerri |
|
1991 |
12 |
5 |
p. 680- 1 p. |
artikel |
134 |
Low cost database management in clinical trials—Riding the tidal wave of technology
|
Duncan, David |
|
1991 |
12 |
5 |
p. 621- 1 p. |
artikel |
135 |
Management of data files in preparation for statistical analysis
|
Raiz, Pauline |
|
1991 |
12 |
5 |
p. 709- 1 p. |
artikel |
136 |
Management of study proposals: From an idea to a manuscript
|
Forman, Sandra |
|
1991 |
12 |
5 |
p. 682- 1 p. |
artikel |
137 |
Measuring screening biases in case fatality analyses with clinical trial data
|
Chu, Kenneth |
|
1991 |
12 |
5 |
p. 640- 1 p. |
artikel |
138 |
Meta-analyses of animal experiments
|
Freedman, Lawrence S. |
|
1991 |
12 |
5 |
p. 656- 1 p. |
artikel |
139 |
Methods of toxicity data collection: An evaluation of the relative effectiveness of the case report flow sheet (FS), the patient symptom diary (SD), and the quality of life questionnaire (QLQ)
|
Paul, Nancy |
|
1991 |
12 |
5 |
p. 648- 1 p. |
artikel |
140 |
Methods to estimate the distribution of the additional stay in hospital due to nosocomial infections
|
Schulgen, Gabi |
|
1991 |
12 |
5 |
p. 627-628 2 p. |
artikel |
141 |
Modelling morbidity of major diseases in a community from a delphi-type data
|
Oranga, H.M. |
|
1991 |
12 |
5 |
p. 640- 1 p. |
artikel |
142 |
Model selection procedures in analyzing case-control studies
|
Blettner, Maria |
|
1991 |
12 |
5 |
p. 641- 1 p. |
artikel |
143 |
Modifications to point summary odds ratio estimators
|
Orozco, Jose Antonio |
|
1991 |
12 |
5 |
p. 688- 1 p. |
artikel |
144 |
Monotone spline additive-risks model
|
Abrahamowicz, Michal |
|
1991 |
12 |
5 |
p. 619- 1 p. |
artikel |
145 |
Mortality probabilistic model for breast cancer screening: Survival effect of several screenings
|
Daures, J.P. |
|
1991 |
12 |
5 |
p. 718-719 2 p. |
artikel |
146 |
Multicenter trials: Analysis with treatment by center interactions
|
Stammer, H. |
|
1991 |
12 |
5 |
p. 627- 1 p. |
artikel |
147 |
Multivariate latent trait models for the analysis of repeated dichotomous measurements
|
Zwinderman, Aellko H. |
|
1991 |
12 |
5 |
p. 647- 1 p. |
artikel |
148 |
Nonparametric and parametric statistical safety screening of clinical trial laboratory data
|
Nitzberg, David M. |
|
1991 |
12 |
5 |
p. 701- 1 p. |
artikel |
149 |
Observed versus expected: Verifying clinical impressions in ophthalmologic trials
|
Diener-West, Marie |
|
1991 |
12 |
5 |
p. 696- 1 p. |
artikel |
150 |
Observer bias superimposed on observer variability: Results of a wine tasting
|
Burdick, Elisabeth |
|
1991 |
12 |
5 |
p. 713- 1 p. |
artikel |
151 |
On the design and analysis of randomized clinical trials with multiple end-points
|
Geller, Nancy L. |
|
1991 |
12 |
5 |
p. 665- 1 p. |
artikel |
152 |
Orientation and training for clinical research personnel: A 5 year perspective
|
Gutknecht, G.D. |
|
1991 |
12 |
5 |
p. 714- 1 p. |
artikel |
153 |
Outcome measures in a clinical trial to compare two methods of management of tibial fractures
|
Raab, Gillian M. |
|
1991 |
12 |
5 |
p. 623- 1 p. |
artikel |
154 |
Parallel randomized and nonrandomized clinical trials: What can we gain?
|
Marcus, Sue M. |
|
1991 |
12 |
5 |
p. 668- 1 p. |
artikel |
155 |
Patient response in a large follow-up by mail
|
Mickel, Mary |
|
1991 |
12 |
5 |
p. 680- 1 p. |
artikel |
156 |
Phase I trials: Is it better to use patients or normal volunteers?
|
Kapit, Richard M. |
|
1991 |
12 |
5 |
p. 658-659 2 p. |
artikel |
157 |
Planning, designing and implementing a prospective meta-analysis study
|
Margitic, Susan E. |
|
1991 |
12 |
5 |
p. 631- 1 p. |
artikel |
158 |
Post-stratification approach to missing data problems in clinical trials
|
Lee, Young Jack |
|
1991 |
12 |
5 |
p. 625- 1 p. |
artikel |
159 |
Predicting physician accrual of patients onto randomized clinical trials: Physician orientation profile
|
Taylor, Kathryn M. |
|
1991 |
12 |
5 |
p. 678-679 2 p. |
artikel |
160 |
Preplanned meta-analyses in a clinical trial aimed at reducing frailty and injuries in older persons
|
Miller, J.P. |
|
1991 |
12 |
5 |
p. 630-631 2 p. |
artikel |
161 |
Presentation of clinical data
|
Altman, Douglas G. |
|
1991 |
12 |
5 |
p. 720-721 2 p. |
artikel |
162 |
Primary prevention trials of cholesterol lowering agents: A tale of three trials
|
Ford, Ian |
|
1991 |
12 |
5 |
p. 697- 1 p. |
artikel |
163 |
Problems in estimating cost effectiveness in clinical trials: Experimental versus implementation costs
|
DeNino, L.A. |
|
1991 |
12 |
5 |
p. 633-634 2 p. |
artikel |
164 |
Problems of covariate adjustment in clinical trials
|
Holle, Rolf |
|
1991 |
12 |
5 |
p. 652- 1 p. |
artikel |
165 |
Process of obtaining NDI information to determine the vital status and cause of death of CASS registry patients
|
Ng, Grace |
|
1991 |
12 |
5 |
p. 707- 1 p. |
artikel |
166 |
Progress and problems in establishing an international registry of perinatal trials (IROPT)
|
Chaimers, lain |
|
1991 |
12 |
5 |
p. 630- 1 p. |
artikel |
167 |
Psychometric models concerning rating scales and inventories as end-point measures in behavioral intervention trials
|
Frick, Ulrich |
|
1991 |
12 |
5 |
p. 624- 1 p. |
artikel |
168 |
Publication practices in NIH-sponsored multicenter clinical trials
|
Hawkins, Barbara S. |
|
1991 |
12 |
5 |
p. 634- 1 p. |
artikel |
169 |
Quality control in the diabetes control and complications trial (DCCT)
|
Owen, Walter |
|
1991 |
12 |
5 |
p. 715- 1 p. |
artikel |
170 |
Quality of life assessment: Patient compliance with questionnaire completion
|
Sadura, Anna |
|
1991 |
12 |
5 |
p. 708-709 2 p. |
artikel |
171 |
Quality of life evaluation in clinical trials in cancer medicine
|
Hoffman, J. |
|
1991 |
12 |
5 |
p. 654- 1 p. |
artikel |
172 |
Qualtification of fluorescence properties of lymphocytes from properties of mixture populations of blood cells: A latent class approach
|
van Putten, W.L.J. |
|
1991 |
12 |
5 |
p. 647- 1 p. |
artikel |
173 |
Randomization by cluster: An example from the field of perinatal trials
|
Elbourne, Diana |
|
1991 |
12 |
5 |
p. 663- 1 p. |
artikel |
174 |
Randomized trials in psychosomatic medicine: Practical solutions to typical design problems
|
Kieser, Meinhard |
|
1991 |
12 |
5 |
p. 694- 1 p. |
artikel |
175 |
Recent developments in statistical methods for evaluating uniformity of treatment effects
|
Simon, Richard |
|
1991 |
12 |
5 |
p. 626- 1 p. |
artikel |
176 |
Recruitment experience in the full scale phase of the modification of diet in renal disease (MDRD) study
|
Kusek, John W. |
|
1991 |
12 |
5 |
p. 678- 1 p. |
artikel |
177 |
Recruitment in three different obstetric randomized controlled trials from a center coordinator's point of view
|
Weston, Julie |
|
1991 |
12 |
5 |
p. 677- 1 p. |
artikel |
178 |
Recruitment of patients into company sponsored clinical trials in Australia
|
Cutler, Stephen A. |
|
1991 |
12 |
5 |
p. 678- 1 p. |
artikel |
179 |
Recursive partition methods for the analysis of prognostic factors in advanced ovarian cancer
|
Valsecchi, M.G. |
|
1991 |
12 |
5 |
p. 687- 1 p. |
artikel |
180 |
Recursive structural model: An approach to analyze data with treatment adherence problem in randomized clinical trials
|
Zee, Benny C. |
|
1991 |
12 |
5 |
p. 625-626 2 p. |
artikel |
181 |
Redefining outcome in an ongoing trial: Convening a consensus panel
|
Hawson, Sheila |
|
1991 |
12 |
5 |
p. 711-712 2 p. |
artikel |
182 |
Reference values and analysis of routine clinical laboratory data in clinical trials
|
Wilson, Michael G. |
|
1991 |
12 |
5 |
p. 703- 1 p. |
artikel |
183 |
Relationship of P-value to conditional and predictive power in interim analysis
|
VanRaden, Mark |
|
1991 |
12 |
5 |
p. 642- 1 p. |
artikel |
184 |
Relationship of tumor response and survival in advanced ovarian cancer patients treated with chemotherapy
|
Torri, Valter |
|
1991 |
12 |
5 |
p. 705- 1 p. |
artikel |
185 |
Repeated measurements designs with a first order autoregressive pattern: Testing circularity and serial correlation
|
Casana, Bruno |
|
1991 |
12 |
5 |
p. 632- 1 p. |
artikel |
186 |
Reporting events in a large clinical trial: A flexible and dynamic database design
|
Steenkiste, Ann R. |
|
1991 |
12 |
5 |
p. 681- 1 p. |
artikel |
187 |
Reporting of toxicity data in prospective clinical trials: Current patterns of practice and implications for analysis
|
Brundage, Michael |
|
1991 |
12 |
5 |
p. 681- 1 p. |
artikel |
188 |
Results from clinical trials: How should they influence other ongoing clinical studies?
|
Laupacis, Andreas |
|
1991 |
12 |
5 |
p. 635- 1 p. |
artikel |
189 |
Risk groups of lung cancer and the model of the people screening
|
Dinya, E. |
|
1991 |
12 |
5 |
p. 673- 1 p. |
artikel |
190 |
Robust logistic regression in diagnosis assistance and clinical trials applications
|
Krusinska, Ewa |
|
1991 |
12 |
5 |
p. 689- 1 p. |
artikel |
191 |
Robust sequential crossover designs for clinical trials
|
Filloon, Tom G. |
|
1991 |
12 |
5 |
p. 694- 1 p. |
artikel |
192 |
Sample size and power for comparing vaccines
|
Blackwelder, William C. |
|
1991 |
12 |
5 |
p. 643- 1 p. |
artikel |
193 |
Sample size for sequentially monitored trials with noncompliance and lag
|
Lakatos, Edward |
|
1991 |
12 |
5 |
p. 638- 1 p. |
artikel |
194 |
Sample size issues for inferences about correlated proportions
|
Elashoff, Janet D. |
|
1991 |
12 |
5 |
p. 669- 1 p. |
artikel |
195 |
Sample sizes of prevention trials have been too small
|
Ederer, Fred |
|
1991 |
12 |
5 |
p. 650-651 2 p. |
artikel |
196 |
Sampling the universe for the bypass angioplasty revascularization investigation
|
Detre, Katherine |
|
1991 |
12 |
5 |
p. 650- 1 p. |
artikel |
197 |
Searching for hidden periodicities in biological time series
|
Carr, David |
|
1991 |
12 |
5 |
p. 710- 1 p. |
artikel |
198 |
Selecting a point estimator of blood pressure from consecutive measurements
|
Gassman, Jennifer J. |
|
1991 |
12 |
5 |
p. 709-710 2 p. |
artikel |
199 |
Serial correlation in the design and analysis of crossover trials
|
Matthews, John N.S. |
|
1991 |
12 |
5 |
p. 659- 1 p. |
artikel |
200 |
Shared quality control in a distributed data entry system
|
Hogan, Patricia E. |
|
1991 |
12 |
5 |
p. 646- 1 p. |
artikel |
201 |
Simulation in clinical trial design
|
Yateman, Nigel A. |
|
1991 |
12 |
5 |
p. 670- 1 p. |
artikel |
202 |
Simultaneous randomization to multiple dose levels and an active comparator as a means of determining the minimal effective dose of an investigational agent
|
Pater, Joseph L. |
|
1991 |
12 |
5 |
p. 696- 1 p. |
artikel |
203 |
Society for clinical trials: Board of directors, officers 1991–1992
|
|
|
1991 |
12 |
5 |
p. 588-589 2 p. |
artikel |
204 |
Sociodemographic characteristics associated with patient enrollment in the collaborative ocular melanoma study
|
Diener-West, Marie |
|
1991 |
12 |
5 |
p. 657-658 2 p. |
artikel |
205 |
So clean it squeaks—comparison of data collected by two independent groups on the same trial
|
Palmer, Michael J. |
|
1991 |
12 |
5 |
p. 693- 1 p. |
artikel |
206 |
Software for the management of large multicenter trials which involve several trials offices
|
Bliss, Judith |
|
1991 |
12 |
5 |
p. 675- 1 p. |
artikel |
207 |
Software solutions for management of clinical data—Present and future
|
Michael, Martin |
|
1991 |
12 |
5 |
p. 664- 1 p. |
artikel |
208 |
Some useful distribution-free multivariate estimators and tests for the analysis of repeated measures in a clinical trial
|
Lachin, John M. |
|
1991 |
12 |
5 |
p. 631- 1 p. |
artikel |
209 |
Sources of variation in clinical center workloads during a 15-year period
|
Keller, Jean A. |
|
1991 |
12 |
5 |
p. 712- 1 p. |
artikel |
210 |
Spectral analysis of the effect of drug treatment on the circadian pattern of blood pressure and angina
|
Gaffney, Michael |
|
1991 |
12 |
5 |
p. 666- 1 p. |
artikel |
211 |
Stability of meta-analysis (M-As) of randomized control trials (RCTs): A retrospective study of 10 published M-As by sequential M-As and the implications for prospective M-As
|
Lau, J. |
|
1991 |
12 |
5 |
p. 705- 1 p. |
artikel |
212 |
Statistical analysis of multiple failures in clinical trials for treatment of drug dependence
|
Jain, Ram B. |
|
1991 |
12 |
5 |
p. 664- 1 p. |
artikel |
213 |
Statistical aspects in the analysis of a breast cancer clinical trial
|
Schmoor, Claudia |
|
1991 |
12 |
5 |
p. 700- 1 p. |
artikel |
214 |
Statistical controversies in meta-analysis: Fixed effects or random effects models?
|
Thompson, S.G. |
|
1991 |
12 |
5 |
p. 626- 1 p. |
artikel |
215 |
Statistical issues addressed in a large screening trial
|
Wleand, S. |
|
1991 |
12 |
5 |
p. 660- 1 p. |
artikel |
216 |
Statistical methods for analyzing heart rate irregularity during atrial fibrillation
|
Jonsson, Robert |
|
1991 |
12 |
5 |
p. 646- 1 p. |
artikel |
217 |
Statistical models for correlated responses in graft patency assessment
|
Marubini, E. |
|
1991 |
12 |
5 |
p. 660- 1 p. |
artikel |
218 |
Statistical models to evaluate the impact of cancer clinical trial advances on population survival
|
Feuer, Eric J. |
|
1991 |
12 |
5 |
p. 618- 1 p. |
artikel |
219 |
Stochastic curtailment—or when should we stop or continue a clinical trial?
|
Ulm, Kurt |
|
1991 |
12 |
5 |
p. 637- 1 p. |
artikel |
220 |
Subgroup analyses in clinical trials
|
McMahon, Robert |
|
1991 |
12 |
5 |
p. 686-687 2 p. |
artikel |
221 |
Subsampling strategies in clinical trials
|
Davis, Vicki G. |
|
1991 |
12 |
5 |
p. 652-653 2 p. |
artikel |
222 |
Surfactant replacement therapy for severe neonatal respiratory distress syndrome: Biometrical aspects and results of the European multicenter randomized clinical trial
|
Gefeller, Olaf |
|
1991 |
12 |
5 |
p. 697-698 2 p. |
artikel |
223 |
Surveillance in medicine
|
Frisen, Marianne |
|
1991 |
12 |
5 |
p. 672- 1 p. |
artikel |
224 |
Survival in cardiac insufficiency after captopril treatment: Midterm analysis
|
Assennato, G. |
|
1991 |
12 |
5 |
p. 699- 1 p. |
artikel |
225 |
Suspended judgment the optimistic bias favoring medical action
|
Silverman, William A. |
|
1991 |
12 |
5 |
p. 557-559 3 p. |
artikel |
226 |
Teaching probabilistic expert system using clinical data
|
Spiegelhalter, David J. |
|
1991 |
12 |
5 |
p. 640-641 2 p. |
artikel |
227 |
Telecommunications: A tool for information dissemination in multicenter clinical trials
|
Crow, Sharon |
|
1991 |
12 |
5 |
p. 675- 1 p. |
artikel |
228 |
Telecommunication techniques in a distributed data entry system for multicenter clinical trials
|
Kamors, Larry |
|
1991 |
12 |
5 |
p. 676- 1 p. |
artikel |
229 |
The analysis of multiple end points with a two-stage group sequential design
|
Legault, Claudine |
|
1991 |
12 |
5 |
p. 667- 1 p. |
artikel |
230 |
The benefits of producing data collection forms the hard way
|
Singer, Stephen W. |
|
1991 |
12 |
5 |
p. 648- 1 p. |
artikel |
231 |
The Canadian abdominal aortic aneurysm (AAA) treatment trial
|
Moher, David |
|
1991 |
12 |
5 |
p. 698- 1 p. |
artikel |
232 |
The changing role of a project manager during a multicenter clinical trial
|
Margitic, Susan E. |
|
1991 |
12 |
5 |
p. 629- 1 p. |
artikel |
233 |
The choice of sequential boundaries based on the concept of power spending
|
Bauer, Peter |
|
1991 |
12 |
5 |
p. 637- 1 p. |
artikel |
234 |
The cost effectiveness of a run-in strategy in a randomized clinical trial
|
Schechtman, Kenneth B. |
|
1991 |
12 |
5 |
p. 633- 1 p. |
artikel |
235 |
The development of PC-based distributed data entry system for the P2C2HIV study
|
McPherson, Joseph A. |
|
1991 |
12 |
5 |
p. 676- 1 p. |
artikel |
236 |
The effect of supervised brushing on evaluating the efficacy of a caries clinical trial
|
Moorhead, Jacquelyn |
|
1991 |
12 |
5 |
p. 713- 1 p. |
artikel |
237 |
The implementation of a voice information system in clinical trials
|
Chow, Bruce |
|
1991 |
12 |
5 |
p. 676- 1 p. |
artikel |
238 |
The importance of counting all the patients
|
Terrin, Michael |
|
1991 |
12 |
5 |
p. 686- 1 p. |
artikel |
239 |
The influence of missing data in the analysis of composite endpoints
|
Thompson, Bruce |
|
1991 |
12 |
5 |
p. 685- 1 p. |
artikel |
240 |
The modification of diet in renal disease study group
|
Beck, Gerald J. |
|
1991 |
12 |
5 |
p. 566-586 21 p. |
artikel |
241 |
The need for multivariate analysis: A survey of uterine sarcoma in the west Midlands health region
|
Dunn, J.A. |
|
1991 |
12 |
5 |
p. 687-688 2 p. |
artikel |
242 |
The perinatal trials service
|
Grant, Adrian |
|
1991 |
12 |
5 |
p. 679- 1 p. |
artikel |
243 |
The questions we have to answer when using QALYS
|
Noack, Herbert |
|
1991 |
12 |
5 |
p. 711- 1 p. |
artikel |
244 |
Therapeutic coverage: A crossover comparison between two drugs of the same class in outpatient practice
|
Heynen, Guy |
|
1991 |
12 |
5 |
p. 668- 1 p. |
artikel |
245 |
Therapeutic coverage: A parameter for analyzing the pharmacodynamic impact of partial patient compliance
|
Urquhart, John |
|
1991 |
12 |
5 |
p. 672- 1 p. |
artikel |
246 |
The relative importance of prognostic factors in studies of survival
|
Schemper, Michael |
|
1991 |
12 |
5 |
p. 639- 1 p. |
artikel |
247 |
The role of comorbidity on the feasibility and outcome of quality of care and effectiveness studies
|
Apolone, G. |
|
1991 |
12 |
5 |
p. 651- 1 p. |
artikel |
248 |
The role of quality of life assessments in clinical trials
|
Fayers, Peter |
|
1991 |
12 |
5 |
p. 653- 1 p. |
artikel |
249 |
The tridimensional personality questionnaire as a predictor of outcome in a randomized trial of nefazodone, imipramine and placebo in depression
|
Schwiderski, Ute |
|
1991 |
12 |
5 |
p. 701- 1 p. |
artikel |
250 |
The use of the propensity score in the analysis of clinical trials
|
Abramowski, Erika |
|
1991 |
12 |
5 |
p. 666- 1 p. |
artikel |
251 |
Thirteenth annual meeting of the Society for clinical trials May 10–13, 1992 Adam's Mark Hotel Philadelphia, Pennsylvania
|
|
|
1991 |
12 |
5 |
p. 587- 1 p. |
artikel |
252 |
Too many trials with too small sample sizes
|
Messerer, Dorle |
|
1991 |
12 |
5 |
p. 650- 1 p. |
artikel |
253 |
Towards a standardization of DDE
|
Bailey, Lance R. |
|
1991 |
12 |
5 |
p. 644- 1 p. |
artikel |
254 |
Towards more “informed” consent in clinical trials: An information booklet for patients and physicians in the UK
|
Easterbrook, Philippa |
|
1991 |
12 |
5 |
p. 657- 1 p. |
artikel |
255 |
Towards reducing observer effects in blood pressure (BP) measurement
|
Hogan, Patricia E. |
|
1991 |
12 |
5 |
p. 709- 1 p. |
artikel |
256 |
Twelfth annual meeting of the society for clinical trials international society for clinical biostatistics
|
|
|
1991 |
12 |
5 |
p. 590-617 28 p. |
artikel |
257 |
Two-step procedure for survival analysis
|
Bartolucci, Alfred A. |
|
1991 |
12 |
5 |
p. 704- 1 p. |
artikel |
258 |
Usefulness of collecting individual data in meta-analyses
|
Pignon, Jean-Pierre |
|
1991 |
12 |
5 |
p. 630- 1 p. |
artikel |
259 |
Use of an artificial neural network for statistical pattern recognition
|
Clarke, Ellis |
|
1991 |
12 |
5 |
p. 641- 1 p. |
artikel |
260 |
Use of computer applications to facilitate retroactive updates to a database
|
Pelusio, Rita M. |
|
1991 |
12 |
5 |
p. 707- 1 p. |
artikel |
261 |
Use of interim analyses to design further studies in drug programs
|
Lipschutz, Katherine |
|
1991 |
12 |
5 |
p. 683- 1 p. |
artikel |
262 |
Use of relational database “views” in clinical trial data management
|
LoPresti, Frances |
|
1991 |
12 |
5 |
p. 620-621 2 p. |
artikel |
263 |
Using the accrual period to update sample size estimates in prevention studies
|
Thornquist, Mark D. |
|
1991 |
12 |
5 |
p. 641-642 2 p. |
artikel |
264 |
Using the foxpro code generator in the development of a distributed data entry system
|
McPherson, Joseph A. |
|
1991 |
12 |
5 |
p. 645-646 2 p. |
artikel |
265 |
Validity of the bootstrap for a Hodges-Lehmann type estimator in the two-sample problem with censoring
|
Bassiakos, Ylannis |
|
1991 |
12 |
5 |
p. 702- 1 p. |
artikel |
266 |
Variability of CD4 counts, a surrogate marker for disease progression in HIV-infected individuals
|
Aber, Victor |
|
1991 |
12 |
5 |
p. 623- 1 p. |
artikel |
267 |
Visualization of clinical data with the SAS(R) system
|
Held, Gerhard |
|
1991 |
12 |
5 |
p. 665- 1 p. |
artikel |
268 |
Visualizing the effect of time-dependent covariates using the Cox model: A simple method and application
|
Thompson, Bruce |
|
1991 |
12 |
5 |
p. 618-619 2 p. |
artikel |
269 |
When to stop an ongoing trial: The case of adjuvant chemotherapy on colon cancer (ACCC)
|
Marsoni, S. |
|
1991 |
12 |
5 |
p. 635- 1 p. |
artikel |